The dynamics of statins: from event prevention to neuroprotection.
Amarenco
Pierre
P
Department of Neurology, Stroke Centre, Denis Diderot University and Medical School, Bichat Hospital, Paris, France. pierre.amarenco@bch.aphp.fr
Moskowitz
Michael A
MA
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology; D002097:C-Reactive Protein / Q000096:biosynthesis; D002986:Clinical Trials as Topic; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D008077:Lipoproteins, LDL / Q000378:metabolism; D018696:Neuroprotective Agents / Q000494:pharmacology; D020521:Stroke / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control*; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008077:Lipoproteins, LDL; D018696:Neuroprotective Agents; D002097:C-Reactive Protein